Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Lymphoma × sargramostim × Clear all

Phase

Phase 2 26 Phase 1 8 Phase 3 2 Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 7 Breast Neoplasms 5 Colorectal Neoplasms 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Uveal Melanoma 2 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Neuroblastoma 2 Neoplasms 2 Multiple Myeloma 2 Lung Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Adenocarcinoma 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Neoplasms, Plasma Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1

Interventions

Cyclophosphamide 39 Rituximab 38 fludarabine 19 Filgrastim 18 Lenalidomide 14 fludarabine phosphate 13 Prednisone 13 Vincristine 12 Peripheral Blood Stem Cell Transplantation 12 Etoposide 12 Doxorubicin 12 Busulfan 12 Radiotherapy 11 Melphalan 11 pembrolizumab 10 Tacrolimus 10 Gemcitabine 9 Methotrexate 8 obinutuzumab 7 Bendamustine Hydrochloride 7 Whole-Body Irradiation 6 Vorinostat 6 Granulocyte Colony-Stimulating Factor 6 Bortezomib 6 Azacitidine 6 Alemtuzumab 6 ibrutinib 5 aldesleukin 5 Mycophenolic Acid 5 Ifosfamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01527422 2012-02-07

CHOP-R

Auxilio Mutuo Cancer Center

Phase 1/2 Completed

Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡